Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model-Reference-Cited by-同舟云学术

Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model

Published:2016-07 Issue: Volume:783 Page:23-32
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Qi Liqin,Ke Linfang,Liu Xiaohong,Liao Lianming,Ke Sujie,Liu Xiaoying,Wang Yanping,Lin Xiaowei,Zhou Yu,Wu Lijuan,Chen Zhou,Liu Libin

Funder

Science and Technology Key Funding of Fujian Province of China

Youth Funding of Fujian Province Health Department

China International Medical Foundation (CIMF)—Novo Nordisk China Diabetes Young Scientific Talent Research Funding

Natural Science Foundation of Fujian Province

Publisher

Elsevier BV

Subject

Pharmacology

Reference46 articles.

1. GSK-3 inhibitor for Alizhermer's diease;Alila;Expert Rev. Neurother.,2007

2. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments;Alonso;Proc. Natl. Acad. Sci. USA,2001

3. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418;Bhat;J. Biol. Chem.,2003

4. Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model.;Chen;Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci.,2012

5. Liraglutide;Drucker;Nat. Rev. Drug Discov.,2010

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges;Life Sciences;2024-10

2. Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis;Journal of Neuroimmune Pharmacology;2024-07-23

3. GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for CombatingAlzheimer’s Disease through its Supporting DPP4 Inhibitors: A Review;Current Topics in Medicinal Chemistry;2024-07

4. Hypoglycemic TCM formulas (Huangqi-Gegen drug pair) have the potential as an Alzheimer's disease;Phytomedicine;2024-07

5. Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects;Frontiers in Pharmacology;2024-06-14